guided by objective measures: challenging case scenarios in rheumatoid arthritis
DESCRIPTION
Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis. Learning Goals. Case 1: Introduction (JS). Validated Quantitative Measures of Disease Activity. Features of Disease Activity Measurement Tools. Features of Disease Activity Measurement Tools (cont). - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/1.jpg)
Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis
![Page 2: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/2.jpg)
![Page 3: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/3.jpg)
Learning Goals
![Page 4: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/4.jpg)
Case 1: Introduction (JS)
![Page 5: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/5.jpg)
![Page 6: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/6.jpg)
Validated Quantitative Measuresof Disease Activity
![Page 7: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/7.jpg)
Features of Disease Activity Measurement Tools
![Page 8: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/8.jpg)
Features of Disease Activity Measurement Tools (cont)
![Page 9: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/9.jpg)
Assessing Disease Activity in RA
![Page 10: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/10.jpg)
Key Principles
![Page 11: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/11.jpg)
ACR Recommendations forTreating Early RA
![Page 12: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/12.jpg)
Poor Prognostic Features
![Page 13: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/13.jpg)
ACR / EULAR Definitions of Remission
![Page 14: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/14.jpg)
A Tablet-based Application to Facilitate Assessment of RA
Disease Activity
![Page 15: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/15.jpg)
The READY Application
![Page 16: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/16.jpg)
Usual Workflow to Collect RADisease Activity Data
![Page 17: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/17.jpg)
Features of the READY iPadApplication
![Page 18: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/18.jpg)
Case 2: Introduction (RM)
![Page 19: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/19.jpg)
Case 2 (cont)
![Page 20: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/20.jpg)
RA Therapies
![Page 21: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/21.jpg)
Switching From DMARDS to Biologics
![Page 22: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/22.jpg)
Switching Among Biologics Due to Lack of Response or Loss of Benefit
![Page 23: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/23.jpg)
Switching Among Biologics Due toAdverse Events
![Page 24: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/24.jpg)
Switching Among Biologics Due toAdverse Events (cont)
![Page 25: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/25.jpg)
Switching Among Biologics Due toAdverse Events (cont)
![Page 26: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/26.jpg)
Abbreviations
![Page 27: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/27.jpg)
Abbreviations (cont)
![Page 28: Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis](https://reader035.vdocuments.us/reader035/viewer/2022062501/56815ee8550346895dcd974d/html5/thumbnails/28.jpg)
References